Federal task force report marks important step for Canada’s life sciences sector
Ottawa, July 24, 2026 – Innovative Medicines Canada (IMC) acknowledges today’s publication of the Pharmaceutical and Life Sciences Sector Task […]
Newsroom
Stay informed on the latest developments in life sciences research, healthcare policy, and innovative medicines.
For media inquiries, please contact us at media@imc-mnc.ca.
PRESS RELEASES
IMC welcomes premiers’ call for sustainable healthcare funding
Ottawa, July 23, 2026 – Innovative Medicines Canada (IMC) welcomes today’s call from Canada’s Premiers, issued at the Council of […]
Innovative Medicines Canada and Roche Canada establish the Brigitte Nolet Scholarship for indigenous pathways into life sciences at York University
Ottawa, November 20, 2025 – Innovative Medicines Canada (IMC) and Roche Canada are proud to announce the creation of the […]
Statements
IMC Statement on new federal government task force
Ottawa, March 18, 2026 – Canada must strengthen its approach to pharmaceutical innovation in a rapidly evolving global environment. Today’s […]
IMC congratulates the government of Québec on launching the new Québec life sciences strategy
Ottawa, December 4, 2025 — Innovative Medicines Canada (IMC) congratulates the Government of Québec on the launch of the new […]
Federal budget statement
November 4, 2025 (Ottawa)—Today’s federal budget outlined ambitious plans to reduce government spending while making generational investments to strengthen Canada’s […]
IN THE NEWS
Opinion: It’s faster to fly a human around the moon than to get a new drug to Canadians
By Dr. Bettina Hamelin Article originally published on Healthing.ca, July 21, 2026. This spring, Canada made history when astronaut Jeremy Hansen […]
Canada’s wait for new medicines is long — and about to get longer
By Dr. Bettina Hamelin Article originally published on healthinsight.ca, June 25, 2026. Global drug policy changes are making it increasingly difficult […]
Canada’s innovation gap: why your access to medicines is at risk
By Dr. Bettina Hamelin Article originally published on the Toronto Star, June 11, 2026. There’s a quiet crisis unfolding behind closed […]
Patient Stories
Areas of work
Better health outcomes start with better policy. Explore the issues where IMC is pushing for change on behalf of patients, healthcare professionals and Canada’s life sciences sector.
Access to medicine
Timely access to new medicines saves lives, improves health outcomes…
Pharmacare
One size does not fit all 97% of Canadians are already eligible for drug coverage. Moving to a one-size-fits-all system […]
Patented Medicine Prices Review Board (PMPRB)
The Patented Medicine Prices Review Board (PMPRB) is responsible for ensuring that patented medicines sold in Canada are not excessively […]
Drugs for rare diseases (DRD)
One in 12 Canadians, two-thirds of them children, lives with a rare disease. IMC advocates for policies that improve and […]
Private drug coverage
The value of private drug coverage in Canada More than 27 million Canadians – nearly 70% of the population – […]
